DisclosureWe earn commission on partner links; ranking is set by clinician-vetted methodology — not advertisers.
74% of patients who stop GLP-1s plan to restart. The titration is shorter the second time (often), but the maintenance dose is the same. Restart strategy matters.
Most prescribers restart at a lower dose (e.g., Wegovy 0.5 mg if previously on 2.4 mg) and titrate over 4-8 weeks to maintenance. Weight loss in the second cycle is comparable to the first if the dose is the same.
Insurance PA may be challenging for restarts (some plans require a fresh BMI documentation). Side effects may return at lower intensity. Behavioral pattern: avoid the "I will stop again at goal weight" loop that drove the original discontinuation.
Real-world data on restart cycles is limited. Calibrate 4-year dataset (May 2026) showed restarters achieve ~80% of original loss within the second cycle if maintenance dose is reached.
Restart honestly: this is likely a long-term medication, like a statin or antihypertensive. The cycling-stop loop drives weight cycling and metabolic stress. Plan the second cycle with a long-term frame.
Editorial summary, not medical advice. Cycling, dose changes, and discontinuation should be coordinated with your prescriber.